Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours

BACKGROUND: Hepatitis B virus (HBV) reactivation may occur with chemotherapy and has significant morbidity and mortality. The United States Centre for Disease Control and Prevention recommends pre-chemotherapy hepatitis B screening for all cancer patients, while the American Society of Clinical Onco...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, W H Y, Soe, P P, Pang, A S L, Lee, S-C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670504/
https://www.ncbi.nlm.nih.gov/pubmed/23652302
http://dx.doi.org/10.1038/bjc.2013.225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670504/
https://www.ncbi.nlm.nih.gov/pubmed/23652302
http://dx.doi.org/10.1038/bjc.2013.225

Ejemplares similares